Josephine K Dermawan
Overview
Explore the profile of Josephine K Dermawan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Warmke L, Ameline B, Fritchie K, Dehner C, Agaimy A, Ud Din N, et al.
Virchows Arch
. 2024 Dec;
PMID: 39641785
Sclerosing epithelioid fibrosarcoma (SEF) was originally described as a peculiar variant of fibrosarcoma in 1995. Subsequent studies showed that conventional SEF was associated with both immunohistochemical expression of MUC4 and...
2.
Isaacson A, Berry R, Ulici V, Armstrong S, Bena J, John I, et al.
Histopathology
. 2024 Nov;
86(5):694-703.
PMID: 39610041
Aims: Epithelioid myxofibrosarcoma (eMFS) is an aggressive morphological variant associated with high rates of local recurrence and metastatic disease. The clinicopathological understanding of this disease is currently limited to a...
3.
Dehner C, Warmke L, Umphress B, Malik F, Cloutier J, Dermawan J, et al.
Mod Pathol
. 2024 Nov;
38(2):100656.
PMID: 39522640
Superficial neurocristic EWSR1::FLI1 fusion tumor is a very recently described, clinically indolent tumor of the skin and superficial soft tissues, which differs in essentially all ways from Ewing sarcoma, despite...
4.
Agaimy A, Antonescu C, Bell D, Breimer G, Dermawan J, Kester L, et al.
Virchows Arch
. 2024 Oct;
PMID: 39387893
The FGFR3::TACC3 fusion has been reported in subsets of diverse cancers including urothelial and squamous cell carcinomas (SCC). However, the morphology of FGFR3::TACC3-positive head and neck carcinomas has not been...
5.
Macedo R, Baranovska-Andrigo V, Pancsa T, Klubickova N, Rubin B, Kilpatrick S, et al.
Histopathology
. 2024 Oct;
86(3):423-432.
PMID: 39381843
Aims: CIC-rearranged sarcomas (CRS) are clinically aggressive undifferentiated round cell sarcomas (URCS), commonly driven by CIC::DUX4. Due to the repetitive nature of DUX4 and the variability of the fusion breakpoints,...
6.
Cyrta J, Dermawan J, Tauziede-Espariat A, Liu T, Rosenblum M, Shroff S, et al.
J Pathol
. 2024 Sep;
264(3):305-317.
PMID: 39344423
CREB gene family (ATF1, CREB1, CREM) fusions with either EWSR1 or FUS gene partners drive the pathogenesis of a wide range of neoplasms, including various soft tissue tumors, intracranial myxoid...
7.
Sharma A, Dermawan J, Chiang S, Wexler L, Antonescu C
Am J Surg Pathol
. 2024 Aug;
PMID: 39210566
Embryonal rhabdomyosarcoma (ERMS) is the most common subtype of RMS, occurring in soft tissue and visceral sites of young children, and is associated with favorable outcomes. A subset occurs in...
8.
Agaimy A, Dermawan J, Haller F, Semrau S, Meidenbauer N, Stoehr R, et al.
Virchows Arch
. 2024 Aug;
485(5):805-813.
PMID: 39196362
With the increasing use of innovative next generation sequencing (NGS) platforms in routine diagnostic and research settings, the genetic landscape of uterine sarcomas has been dynamically evolving during the last...
9.
Dermawan J, Abramson D, Chiang S, Hensley M, Tap W, Movva S, et al.
Clin Cancer Res
. 2024 Aug;
30(20):4780-4790.
PMID: 39150540
Purpose: Leiomyosarcomas (LMS) are clinically and molecularly heterogeneous, occurring mostly in sporadic but also syndromic settings. The role of pathogenic germline variants (PGV) as LMS drivers and their impact on...
10.
Dermawan J, Malik F, Gross J, Baraban E, Pratilas C, Mneimneh W, et al.
Mod Pathol
. 2024 Aug;
37(11):100594.
PMID: 39147032
Alveolar rhabdomyosarcoma (ARMS) with FOXO1 gene rearrangements is an aggressive pediatric rhabdomyosarcoma subtype that is prognostically distinct from embryonal rhabdomyosarcoma and fusion-negative ARMS. Here, we report 2 cases of ARMS...